Lasa Supergenerics (NSE:LASA) LT-Debt-to-Total-Asset: 0.00 (As of Mar. 2026)

What is Lasa Supergenerics LT-Debt-to-Total-Asset?

Lasa Supergenerics NSE:LASA -0.95% 38 LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus rates NSE:LASA with a GF Score™ of 38/100 and a GF Value™ of ₹4.33 (Significantly Overvalued). The stock has 6 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Lasa Supergenerics's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.00.

Lasa Supergenerics's long-term debt to total assets ratio stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00).

Lasa Supergenerics (NSE:LASA) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Lasa Supergenerics LT-Debt-to-Total-Asset Related Terms

Lasa Supergenerics LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Lasa Supergenerics's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lasa Supergenerics LT-Debt-to-Total-Asset Chart

Lasa Supergenerics Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.00

Lasa Supergenerics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

38GF Score

Lasa Supergenerics Ltd NSE:LASA

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Lasa Supergenerics LT-Debt-to-Total-Asset Calculation

Lasa Supergenerics's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )	/	Total Assets (A: Mar. 2026 )
	=	0	/	662.718
	=	0.00

Lasa Supergenerics's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	0	/	662.718
	=	0.00

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.00 mean?

Lasa Supergenerics (NSE:LASA) has a LT-Debt-to-Total-Asset of 0.00 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Lasa Supergenerics and its competitors.

Is Lasa Supergenerics' LT-Debt-to-Total-Asset too high?

Lasa Supergenerics' current LT-Debt-to-Total-Asset is 0.00. Overall, Lasa Supergenerics has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Lasa Supergenerics' LT-Debt-to-Total-Asset compare to ZTS and UTHR?

Lasa Supergenerics' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?

A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Lasa Supergenerics and its competitors. Lasa Supergenerics's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Lasa Supergenerics stock overvalued right now?

Based on GuruFocus' analysis, Lasa Supergenerics (NSE:LASA) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹4.33, compared to a current price of ₹7.30 — trading 68.6% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Lasa Supergenerics' overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Lasa Supergenerics (NSE:LASA), the current LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lasa Supergenerics (NSE:LASA) Overvalued in 2026?

Based on GuruFocus' analysis, Lasa Supergenerics stock appears to be overvalued. The current stock price of ₹7.30 is trading 68.6% above its estimated GF Value™ of ₹4.33. GuruFocus considers Lasa Supergenerics to be Significantly Overvalued.

Key valuation signals for NSE:LASA:

LT-Debt-to-Total-Asset: 0.00
GF Value™: ₹4.33 vs. price of ₹7.30 (68.6% above fair value)
GF Score™: 38/100 with 6 warning signs

No single metric tells the full story. See the NSE:LASA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lasa Supergenerics Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies BOM:524703 BOM:542248 BOM:524711 NSE:JFLLIFE BOM:539938 BOM:532637 BOM:540359 NSE:MEDIORG BOM:524314 BOM:532660 XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges 540702:India

Address Plot No C-4, C-4/1, MIDC, Lote Parshuram Industrial Area, Khed Taluka, Ratnagiri, MH, IND, 415722

Website https://www.lasalabs.com

Lasa Supergenerics Ltd is engaged in the research, manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and related products. The company specializes in catalyst chemistry and manufactures anthelmintic and veterinary API products. Its product range includes API products, other API products, animal feed ingredients, and reagents for therapeutic use.

38GF Score

Get the complete analysis for NSE:LASA

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.30

Price

₹4.33

GF Value

View NSE:LASA Analysis

See LT-Debt-to-Total-Asset data for all stocks →